Stereotactic radiosurgery for jugular foramen schwannomas: an international multicenter study

J Neurosurg. 2018 Oct;129(4):928-936. doi: 10.3171/2017.5.JNS162894. Epub 2017 Nov 10.

Abstract

Objective: For some jugular foramen schwannomas (JFSs), complete resection is possible but may be associated with significant morbidity. Stereotactic radiosurgery (SRS) is a minimally invasive alternative or adjunct to microsurgery for JFSs. The authors reviewed clinical and imaging outcomes of SRS for patients with these tumors.

Methods: Nine participating centers of the International Gamma Knife Research Foundation identified 92 patients who underwent SRS between 1990 and 2013. Forty-one patients had prior subtotal microsurgical resection. The median interval between previous surgery and SRS was 15 months (range 0.5-144 months). Eighty-four patients had preexisting cranial nerve (CN) symptoms and signs. The median tumor volume was 4.1 cm3 (range 0.8-22.6 cm3), and the median margin dose was 12.5 Gy (range 10-18 Gy). Patients with neurofibromatosis were excluded from this study.

Results: The median follow-up was 51 months (range 6-266 months). Tumors regressed in 47 patients, remained stable in 33, and progressed in 12. The progression-free survival (PFS) was 93% at 3 years, 87% at 5 years, and 82% at 10 years. In the entire series, only a dumbbell shape (extension extracranially via the jugular foramen) was significantly associated with worse PFS. In the group of patients without prior microsurgery (n = 51), factors associated with better PFS included tumor volume < 6 cm3 (p = 0.037) and non-dumbbell-shaped tumors (p = 0.015). Preexisting cranial neuropathies improved in 27 patients, remained stable in 51, and worsened in 14. The CN function improved after SRS in 12% of patients at 1 year, 24% at 2 years, 27% at 3 years, and 32% at 5 years. Symptomatic adverse radiation effects occurred in 7 patients at a median of 7 months after SRS (range 5-38 months). Six patients underwent repeat SRS at a median of 64 months (range 44-134 months). Four patients underwent resection at a median of 14 months after SRS (range 8-30 months).

Conclusions: Stereotactic radiosurgery proved to be a safe and effective primary or adjuvant management approach for JFSs. Long-term tumor control rates and stability or improvement in CN function were confirmed.

Keywords: CN = cranial nerve; GKS = Gamma Knife surgery; Gamma Knife; IGKRF = International Gamma Knife Research Foundation; JFS = jugular foramen schwannoma; PFS = progression-free survival; SRS = stereotactic radiosurgery; jugular foramen schwannoma; stereotactic radiosurgery.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Glomus Jugulare Tumor / diagnostic imaging
  • Glomus Jugulare Tumor / mortality
  • Glomus Jugulare Tumor / surgery*
  • Head and Neck Neoplasms / diagnostic imaging
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / surgery*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Microsurgery / methods
  • Middle Aged
  • Neoplasm, Residual / mortality
  • Neoplasm, Residual / surgery
  • Neurilemmoma / diagnostic imaging
  • Neurilemmoma / mortality
  • Neurilemmoma / surgery*
  • Progression-Free Survival
  • Radiosurgery / methods*
  • Reoperation
  • Young Adult